VEBRISSE Trademark

Trademark Overview


On Friday, January 18, 2008, a trademark application was filed for VEBRISSE with the United States Patent and Trademark Office. The USPTO has given the VEBRISSE trademark a serial number of 77375366. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2009. This trademark is owned by Eli Lilly and Company. The VEBRISSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; pharmaceutical preparations for the prevention of diabetes; antipsychotic agents; and antidepressants; Veterinary preparations for companion an...
vebrisse

General Information


Serial Number77375366
Word MarkVEBRISSE
Filing DateFriday, January 18, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 14, 2008

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; pharmaceutical preparations for the prevention of diabetes; antipsychotic agents; and antidepressants; Veterinary preparations for companion animals in the treatment of weight loss, obesity, urine spraying, chronic pain, gastrointestinal disorders, neurodegenerative disorders, parasitic infestations, neurological disorders, anxiety, hypertension, dermatitis, cancer, anemia associated with chronic renal failure, fleas, pain associated with orthopedic and soft tissue surgery, chronic kidney disease, and emesis; veterinary preparations for the treatment, control and symptomatic relief of infectious and metabolic diseases of livestock

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 23, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, August 10, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 10, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 6, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 14, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 24, 2008NOTICE OF PUBLICATION
Wednesday, September 10, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 5, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 5, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 4, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 4, 2008TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 18, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 18, 2008FINAL REFUSAL E-MAILED
Monday, August 18, 2008FINAL REFUSAL WRITTEN
Tuesday, July 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 21, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2008ASSIGNED TO LIE
Monday, July 21, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 16, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 16, 2008NON-FINAL ACTION E-MAILED
Wednesday, April 16, 2008NON-FINAL ACTION WRITTEN
Tuesday, April 15, 2008ASSIGNED TO EXAMINER
Wednesday, January 23, 2008NEW APPLICATION ENTERED IN TRAM